PX1 Research provides reference-grade Gonadorelin peptid synthesized exclusively for in vitro and preclinical laboratory applications. As a crucial tool for investigating gonadotropin-releasing hormone (GnRH) receptor signaling and the hypothalamic-pituitary-gonadal (HPG) axis, our research compounds undergo rigorous analytical verification to ensure absolute lot-to-lot consistency.
PX1 Research provides reference-grade Gonadorelin peptid synthesized exclusively for in vitro and preclinical laboratory applications. As a crucial tool for investigating gonadotropin-releasing hormone (GnRH) receptor signaling and the hypothalamic-pituitary-gonadal (HPG) axis, our research compounds undergo rigorous analytical verification to ensure absolute lot-to-lot consistency.
To shop gonadorelin peptid for laboratory research, qualified investigators require analytical-grade material backed by comprehensive mass spectrometry and high-performance liquid chromatography verification. Gonadorelin is a synthetic decapeptide identical in sequence to native endogenous gonadotropin-releasing hormone (GnRH), studied extensively in cellular and animal models to evaluate pituitary gonadotrope stimulation, lutropin (LH) release, and follitropin (FSH) secretion dynamics.
When purchasing reference peptides for experimental assays, selecting a domestic supplier that enforces stringent quality control protocols is critical to preventing variable baseline data. PX1 Research manufactures and tests all reagents within ISO 17025 accredited, GMP-compliant facilities based in the United States, providing complete analytical transparency for institutional research teams.
Gonadorelin is a pyroglutamyl decapeptide with the chemical sequence Pyroglutamyl-Histidyl-Tryptophyl-Seryl-Tyrosyl-Glycyl-Leucyl-Arginyl-Prolyl-Glycine amide (pE-H-W-S-Y-G-L-R-P-G-NH2). In molecular assays, this conserved sequence binds specifically to the G-protein coupled gonadotropin-releasing hormone receptor (GnRH-R) located on the plasma membrane of anterior pituitary gonadotropes. Binding initiates a downstream signaling cascade mediated by Gq/11 proteins, activating phospholipase C (PLC) and resulting in intracellular calcium mobilization and protein kinase C (PKC) phosphorylation.
Preclinical investigation reveals that the structural integrity of both the N-terminal pyroglutamyl residue and the C-terminal glycinamide is required for full receptor activation and signal transduction. Researchers utilizing gonadorelin peptid in binding assays observe that native-sequence agonists demonstrate rapid receptor association and dissociation kinetics compared to modified, long-acting synthetic GnRH analogs. This makes the native decapeptide an essential reference control when evaluating receptor internalisation, desensitization rates, and downstream gene transcription in pituitary cell cultures.
In animal models, Gonadorelin serves as the primary pharmacological tool for dissecting pulsatile versus continuous gonadotropin secretion dynamics. In vitro perifusion studies on rat anterior pituitary cells demonstrate that pulsatile exposure to Gonadorelin triggers immediate, concentration-dependent spikes in LH and FSH release. Conversely, continuous administration results in the downregulation of membrane GnRH receptors, uncoupling the receptor from downstream G-protein complexes and causing a rapid decrease in gonadotropin output.
Data from non-human primate research further highlight the role of Gonadorelin in modulating hypothalamic feedback loops. Investigators exploring reproductive endocrinology evaluate how variations in pulse frequency and amplitude alter the differential gene expression of the LH beta-subunit and FSH beta-subunit. Through precise dosing in microfluidic organ-on-a-chip models, researchers can accurately replicate complex endocrine signaling networks, confirming the compound's status as a gold-standard reagent in neuroendocrine studies.
When establishing experimental protocols within neuroendocrinology, researchers often compare native Gonadorelin against modified synthetic GnRH agonist analogs to assess binding affinity, enzymatic resistance, and biological half-life. While native Gonadorelin possesses an in vitro half-life of only several minutes due to rapid cleavage by endopeptidases, modified analogs incorporate structural substitutions at position 6 or the C-terminus to retard enzymatic degradation.
In comparative preclinical literature, compounds such as triptorelin research peptide, leuprolide research peptid, and buserelin sequence analogs demonstrate significantly higher potency and prolonged receptor occupancy compared to unmodified Gonadorelin. While these modified analogs are ideal for sustained receptor desensitization studies, native Gonadorelin remains the preferred candidate for short-duration stimulation assays, baseline physiological mapping, and comparative kinetics experiments. Institutional researchers seeking a comprehensive array of hypothalamic signal modulators can explore our full catalog of research peptides for complementary experimental models.
To achieve reproducible data in cell culture and animal tissue models, research compounds must be free from synthesis by-products, truncated peptides, and bacterial endotoxins. PX1 Research subject every production batch of Gonadorelin to a comprehensive battery of analytical evaluations prior to release. High-Performance Liquid Chromatography (RP-HPLC) verifies chromatographic purity, ensuring that the target peptide peak meets or exceeds a strict 98.0% threshold.
Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular weight (1182.3 g/mol), verifying sequence fidelity without amino acid deletion or misincorporation. Furthermore, because bacterial lipopolysaccharides (LAL) introduce significant experimental noise into cell viability and signaling assays, our ISO 17025 accredited testing protocols include quantitative chromogenic LAL assays to ensure endotoxin levels remain below 0.01 EU/mg. Every order includes a lot-specific Certificate of Analysis (COA) directly downloadable from our research portal.
Proper handling and reconstitution procedures are essential for preserving decapeptide tertiary conformation and preventing aggregation or non-specific vessel binding. Lyophilized Gonadorelin powder should be allowed to equilibrate to room temperature inside a desiccated biosafety cabinet prior to reconstitution to prevent condensation accumulation inside the vial.
For baseline cellular assays, reconstitution should be performed using sterile, deionized water or phosphate-buffered saline (PBS, pH 7.4). If long-term storage of reconstituted stock solution is required for automated microfluidic systems, incorporating 0.1% endotoxin-free Bovine Serum Albumin (BSA) or research-grade bacteriostatic water prevents adsorption to polypropylene microcentrifuge tubes. Researchers should strictly avoid vigorous vortexing; gentle swirling or low-speed orbital agitation is recommended to yield a clear, colorless solution suitable for precision micro-pipetting.
Decapeptide stability depends heavily on storage temperature, humidity control, and protection from ultraviolet light. In its desiccated, lyophilized state, Gonadorelin remains stable at -20°C for up to 24 months, or at -80°C for extended archival preservation. Vials are sealed under inert nitrogen atmospheres to eliminate oxidative degradation of sensitive amino acids such as Tryptophan (Trp3) and Tyrosine (Tyr5).
Once reconstituted into aqueous liquid solution, the peptide exhibits reduced stability due to hydrolysis. Reconstituted stock solutions stored at 4°C should be utilized within 5 to 7 days. For extended experimental timelines spanning multiple weeks, stock solutions should be aliquoted into single-use polypropylene cryovials and frozen at -80°C to avoid repeated freeze-thaw cycles, which induce peptide degradation and structural cleavage.
Securing consistent, high-purity research materials requires a trustworthy domestic supply chain tailored to academic laboratories, biotechnology firms, and contract research organizations (CROs). PX1 Research operates state-of-the-art dispatch facilities in California and Arizona, providing same-day shipping for all orders placed Monday through Friday prior to cutoff times.
Principal investigators and laboratory managers requiring high-volume orders or recurring batch deliveries can set up specialized accounts via our wholesale peptide portal. PX1 Research guarantees full lot traceability, transparent analytical reporting, and dedicated technical support, ensuring your laboratory's experimental timelines remain uninterrupted by supply chain inconsistencies.
What is the primary mechanism of action for Gonadorelin in research models?
In preclinical research models, Gonadorelin acts as a direct agonist at the gonadotropin-releasing hormone receptor (GnRH-R) on anterior pituitary gonadotropes, stimulating Gq/11 protein signaling to trigger the intracellular cascade that releases LH and FSH.
What analytical documentation accompanies PX1 Research peptides?
Every lot of Gonadorelin shipped by PX1 Research includes a comprehensive Certificate of Analysis (COA) detailing RP-HPLC purity profiles (>98%), mass spectrometry mass verification, and quantitative LAL endotoxin testing data.
How does Gonadorelin differ from synthetic long-acting GnRH agonists?
Native Gonadorelin features an unmodified amino acid sequence identical to endogenous GnRH, resulting in a short half-life ideal for pulsatile stimulation studies. Long-acting analogs like Triptorelin or Leuprolide contain structural modifications designed to extend receptor binding duration.
What is the recommended reconstitution solvent for in vitro assays?
For standard cellular and tissue assays, lyophilized Gonadorelin should be reconstituted using sterile laboratory-grade water or phosphate-buffered saline (PBS, pH 7.4). 0.1% BSA may be added to prevent peptide adhesion to tube walls.
What is the molecular weight and chemical formula of Gonadorelin?
Gonadorelin has a molecular formula of C55H75N17O13 and a calculated exact molecular weight of 1182.3 g/mol.
How should reconstituted Gonadorelin solutions be stored?
Reconstituted liquid solutions should be stored at 4°C for short-term use (up to 7 days) or aliquoted and frozen at -80°C for long-term storage to prevent peptide degradation from repeated freeze-thaw cycles.
Where does PX1 Research manufacture and ship its research compounds?
All PX1 Research compounds are manufactured in domestic, GMP-compliant US facilities and dispatched directly from warehouse hubs in California and Arizona with same-day shipping Monday through Friday.
Can Gonadorelin be used in human clinical or diagnostic procedures?
No. All compounds supplied by PX1 Research, including Gonadorelin, are strictly intended for in vitro, cellular, and preclinical laboratory research use only. They are not cleared or intended for human, clinical, or therapeutic applications.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.